← FDA DRUG APPROVALS

FDA ANDA · ANDA070496

NALOXONE

Sponsor: HIKMA

APPLICATION
ANDA070496
TYPE
ANDA
ORIGINAL APPROVAL
1985-10-22
LATEST ACTION
1987-12-18
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

NALOXONEDiscontinued
NALOXONE HYDROCHLORIDE 0.4MG/ML · INJECTABLE · INJECTION

Approval history

1987-12-18Manufacturing (CMC) · Supplement 3AP
1987-12-18Manufacturing (CMC) · Supplement 1AP
1987-01-29Manufacturing (CMC) · Supplement 5AP
1986-12-19Manufacturing (CMC) · Supplement 4AP
1986-12-19Manufacturing (CMC) · Supplement 7AP
1986-11-03Manufacturing (CMC) · Supplement 6AP
1985-10-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →